FacPad: Bayesian sparse factor modeling for the inference of pathways responsive to drug treatment

Bioinformatics

Volumn 28, Issue 20, 2012, Pages 2662-2670

  Ma, Haisu ^a   Zhao, Hongyu ^a  

^a YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTOME;

ALGORITHM; ARTICLE; BAYES THEOREM; COMPUTER PROGRAM; DNA MICROARRAY; DRUG EFFECT; DRUG SCREENING; GENE EXPRESSION PROFILING; GENOME; HUMAN; STATISTICAL MODEL; TUMOR CELL LINE;

ALGORITHMS; BAYES THEOREM; CELL LINE, TUMOR; DRUG EVALUATION, PRECLINICAL; GENE EXPRESSION PROFILING; GENOME; HUMANS; MODELS, STATISTICAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SOFTWARE; TRANSCRIPTOME;

EID: 84870461533     PISSN: 13674803     EISSN: 14602059     Source Type: Journal    
DOI: 10.1093/bioinformatics/bts502     Document Type: Article

References (40)

1. Bader, G.D. et al. (2006) Pathguide: a Pathway Resource List. Nucleic Acids Res., 34, D504-D506.
2. Berti, E. et al. (1998) Mometasone furoate decreases adhesion molecule expression in psoriasis. Eur. J. Dermatol, 8, 421-426.
3. Brettschneider, J. et al. (2008) Quality assessment for short oligonucleotide micro-array data. Technometrics, 50, 241-264.
4. Campillos, M. et al. (2008) Drug target identification using side-effect similarity. Science, 321, 263-266.
5. Caspi, R. et al. (2012) The MetaCyc database of metabolic pathways and enzymes and the BioCyc collection of pathway/genome databases. Nucleic Acids Res., 40, D742-D753.
6. Davis, A.P. et al. (2011) The Comparative Toxicogenomics Database: update 2011. Nucleic Acids' Res., 39, D1067-D1072.
7. rd Int. Conf. Machine Learn, 233-240.
8. He, Z. et al. (2010) Predicting drug-target interaction networks based on functional groups and biological features. PLoS One, 5, e9603.
9. Huang da, W. et al. (2009a) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res., 37, 1-13.
10. Huang da, W. et al. (2009b) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc, 4, 44-57.
11. Hue, M. et al. (2010) Large-scale prediction of protein-protein interactions from structures. BMC Bioinformatics, 11, 144.
12. Iorio, F. et al. (2009) Identifying network of drug mode of action by gene expression profiling. J. Comput. Biol., 16, 241-251.
13. Iorio, F. et al. (2010) Discovery of drug mode of action and drug repositioning from transcriptional responses. Proc. Natl. Acad. Sei. USA., 107, 14621-14626.
14. Iskar, M. et al. (2010) Drug-induced regulation of target expression. PloS Comput. Biol., 6, el000925.
15. Kanehisa, M. et al. (2012) KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res., 40, D109-D114.
16. Kitchen, D.B. et al. (2004) Docking and scoring in virtual screening for drug discovery: methods and applications. Nat. Rev. Drug Discov., 3, 935-949.
17. Kotera, M. et al. (2012) The KEGG databases and tools facilitating omics analysis: latest developments involving human diseases and pharmaceuticals. Methods Mol. Biol., 802, 19-39.
18. Lamb, J. (2007) The Connectivity Map: a new tool for biomedical research. Nat. Rev. Cancer, 7, 54-60.
19. Lamb, J. et al. (2006) The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease. Science, 313, 1929-1935.
20. Lane, M.A. and Bailey, SJ. (2005) Role of retinoid signalling in the adult brain. Prog. Neurobiol, 75, 275-293.
21. Luthi-Carter, R. et al. (2000) Decreased expression of striatal signaling genes in a mouse model of Huntington's disease. Hum. Mol. Genet., 9, 1259-1271.
22. Ma, H. and Zhao, H. (2012) iFad: an integrative factor analysis model for drug-pathway association inference. Bioinformatics, 28, 1911-8.
23. Mootha, V.K. et al. (2003) PGC-1 alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet., 34, 267-273.
24. Nagamine, N. et al. (2009) Integrating statistical predictions and experimental verifications for enhancing protein-chemical interaction predictions in virtual screening. PLoS Comput. Biol, 5, el000397.
25. O'Reilly, K.C. et al. (2006) Chronic administration of 13-cis-retinoic acid increases depression-related behavior in mice. Neuropsychopharmacology, 31, 1919-1927.
26. Pournara, I. and Wernisch, L. (2007) Factor analysis for gene regulatory networks and transcription factor activity profiles. BMC Bioinformatics, 8, 61.
27. Rattray, M. et al (2009) Inference algorithms and learning theory for Bayesian sparse factor analysis. J. Phys.: Conf. Ser. 197, 012002 doi:10.1088/1742-6596/197/1/012002.
28. Sabatti, C. and James, GM. (2006) Bayesian sparse hidden components analysis for transcription regulation networks. Bioinformatics, 22, 739-746.
29. Shoemaker, RH. (2006) The NCI60 human tumour cell line anticancer drug screen. Nat. Rev. Cancer, 6, 813-823.
30. Smalley, J.L. et al (2010) Application of connectivity mapping in predictive toxicology based on gene-expression similarity. Toxicology, 268, 143-146.
31. Subramanian, A. et al (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sei USA., 102, 15545-15550.
32. Tsumuro, T. et al (2005) Effects of mometasone furoate on a rat allergic rhinitis model. Eur. J. Pharmacol, 524, 155-158.
33. Vina, D. et al (2009) Alignment-free prediction of a drug-target complex network based on parameters of drug connectivity and protein sequence of receptors. Mol Pharm., 6, 825-835.
34. West, M. (2003) Bayesian factor regression models in the 'Large p, Small n' paradigm. Bayesian Stat, 7, 733-742.
35. Xie, L. et al (2012) Novel computational approaches to polypharmacology as a means to define responses to individual drugs. Annu. Rev. Pharmacol Toxicol, 52, 361-379.
36. Yamanishi, Y. et al (2008) Prediction of drug-target interaction networks from the integration of chemical and genomic spaces. Bioinformatics, 24, i232-i240.
37. Yamanishi, Y. et al (2010) Drug-target interaction prediction from chemical, genomic and pharmacological data in an integrated framework. Bioinformatics, 26, i246-i254.
38. Young, D.W. et al (2008) Integrating high-content screening and ligand-target prediction to identify mechanism of action. Nat. Chem. Biol, 4, 59-68.
39. Zhao, S. and Iyengar, R. (2012) Systems pharmacology: network analysis to identify multiscale mechanisms of drug action. Annu. Rev. Pharmacol. Toxicol, 52, 505-521.
40. Zhou, T. et al (2010) Solving the apparent diversity-accuracy dilemma of recom-mender systems. Proc. Natl. Acad. Sei. USA., 107, 4511-4515.